López-Alegría Fanny, Poblete Orlando Quezada, De Lorenzi Dino Soares, Oyanedel Juan Carlos Sepúlveda
School of Nursing, Universidad Andres Bello, Santiago, Chile.
Complejo Asistencial Barros Luco, Santiago, Chile.
Sao Paulo Med J. 2015 Nov-Dec;133(6):480-7. doi: 10.1590/1516-3180.2014.9142511. Epub 2015 Oct 9.
Worldwide, there is no single strategy for optimal management of patients with ASCUS (atypical squamous cells of undetermined significance) cytology reports. The objective of this study was to determine the kind of clinical management conducted among women with a first ASCUS Pap smear report.
Prospective single cohort study at a cervical pathology unit in Santiago, Chile.
This was an epidemiological, descriptive, observational and quantitative follow-up study on a cohort of women with ASCUS cytological reports.
In the screening phase, 92,001 cervical cytological smears were collected in primary healthcare clinics. In the diagnostic phase, all women with a first ASCUS report were selected (n = 446). These women were asked to undergo the Pap test again and it was found that 301 women had normal results, 62 women had abnormal results and 83 did not repeat the test. In the diagnostic confirmation phase, the 62 women with abnormal results underwent colposcopy and, from these results, 58 of them underwent a biopsy. The results from the biopsies showed that 16 women had negative histological reports, 13 had CIN 1 and 29 had CIN 2+. In the treatment phase, the 42 women with lesions underwent a variety of treatments, according to the type of lesion. In the post-treatment phase, cytological and colposcopic monitoring was instituted.
The clinical management consisted of traditional management of screening, diagnosis, diagnostic confirmation, treatment and post-treatment monitoring.
在全球范围内,对于非典型鳞状细胞意义不明确(ASCUS)细胞学报告患者的最佳管理尚无单一策略。本研究的目的是确定初次ASCUS巴氏涂片报告的女性所接受的临床管理类型。
在智利圣地亚哥的一个宫颈病理科进行的前瞻性单队列研究。
这是一项对有ASCUS细胞学报告的女性队列进行的流行病学、描述性、观察性和定量随访研究。
在筛查阶段,在初级保健诊所收集了92,001份宫颈细胞学涂片。在诊断阶段,选取了所有初次ASCUS报告的女性(n = 446)。这些女性被要求再次进行巴氏试验,结果发现301名女性结果正常,62名女性结果异常,83名未重复检测。在诊断确认阶段,62名结果异常的女性接受了阴道镜检查,其中58名接受了活检。活检结果显示,16名女性组织学报告为阴性,13名患有CIN 1,29名患有CIN 2+。在治疗阶段,42名有病变的女性根据病变类型接受了各种治疗。在治疗后阶段,进行了细胞学和阴道镜监测。
临床管理包括筛查、诊断、诊断确认、治疗和治疗后监测的传统管理。